MARKER THERAPEUTICS, INC. Gain (Loss) on Derivative Instruments, Net, Pretax
MARKER THERAPEUTICS, INC. (MRKR) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$9.31 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2017-03-14
- MARKER THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2015-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2015-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2015-06-30 was $0.00.
- MARKER THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2015-03-31 was -$9.31M.
- MARKER THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2015 was -$9.31M.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-14 | $0.00 derived: sum of 2 quarters · filed 2017-03-14 | $0.00 derived: sum of 3 quarters · filed 2017-03-14 | -$9.31M 10-K · filed 2017-03-14 | ||
| 2015-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2016-04-14 | $0.00 derived: sum of 2 quarters · filed 2016-04-14 | -$9.31M 10-Q/A · filed 2016-04-14 | |||
| 2015-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-04-14 | -$9.31M 10-Q/A · filed 2016-04-14 | -$2.09M 10-Q · filed 2015-08-14 | |||
| 2015-03-31 | -$9.31M 10-Q/A · filed 2016-04-14 | -$2.09M 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |